共 117 条
[3]
FORMULARY EVALUATION OF 2ND-GENERATION CEPHAMYCIN DERIVATIVES USING DECISION-ANALYSIS
[J].
AMERICAN JOURNAL OF HOSPITAL PHARMACY,
1991, 48 (10)
:2146-2150
[4]
Bergemann R, 1993, Pharmacoeconomics, V3, P131, DOI 10.2165/00019053-199303020-00006
[7]
DECISION-ANALYSIS TO ASSESS COST-EFFECTIVENESS OF LOW-OSMOLALITY CONTRAST-MEDIUM FOR INTRAVENOUS UROGRAPHY
[J].
AMERICAN JOURNAL OF HOSPITAL PHARMACY,
1992, 49 (03)
:577-584
[8]
Cantor S B, 1993, Pharmacoeconomics, V3, P244, DOI 10.2165/00019053-199303030-00007
[9]
COST AND BENEFIT OF SECONDARY PROPHYLAXIS FOR PNEUMOCYSTIS-CARINII PNEUMONIA
[J].
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION,
1991, 266 (06)
:820-824
[10]
CASTIEL C, 1992, PHARMACOECONOMICS, V1, P438